Eating Disorders and Substance Abuse

James M. Greenblatt, M.D.Chief Medical Officer

Walden Behavioral Care

Not Otherwise Specified?

• 147/165 ED patients diagnosed with EDNOS (May 2007)

• The majority of patients with Eating Disorders are given a diagnosis without specified criteria

Anorexia – A Life Threatening Illness

• Anorexia Nervosa has the highest mortality rate of any psychiatric disorder. The most common causes of death are complications of starvation and suicide.

• The mortality rate at five years is 5%, increasing to 20% at 20 years F/U (APA 2000)

• The highest predictor of mortality is?

Eating Disorders and Substance Abuse

• One of the strongest and most consistent predictors of fatal outcome for patients with Anorexia Nervosa was severity of alcohol abuse during follow-up!

The highest rates of suicide attempts are reported among bulimic individuals who have co-morbid alcohol abuse (54%).

(Eating Disorders 2002; 10:205)

Eating Disorders and Substance Abuse

The National Center on Addiction and Substance Abuse (CASA)– between 30 and 50% of individuals with

Bulimia Nervosa abuse or are dependent on drugs or alcohol

– 12-18% with Anorexia Nervosa abuse or are dependent on drugs or alcohol

– compared with 9% of the general population

Eating Disorders and Substance Abuse

• 35% of people who abuse drugs and alcohol have an eating disorder, compared to 3% of the general population.

• The lack of awareness and understanding of the link between eating disorders and substance abuse has led to limited treatment options for patients.

Similarities Between ED and SUD

1. Life Threatening

2. Chronic Relapsing Course

3. Long Term

4. Compulsiveness

5. Ritualistic Behaviors

6. Resistant to Treatment

7. Begin with experimentation; only a small percentage lose control

8. Lead to chronic compromised nutritional and medical complications

DIFFERENCES - CRAVINGS

Alcohol/Drugs

• Driven by the on-going craving to get another drink or drug.

Eating Disorders

• Driven by the need to avoid or overcome the substance (food).

• Driven by the feeling following binge

• Driven by the feeling following purge

Eating Disorders and Substance Abuse

Drugs that Decrease Eating

• Alcohol• Amphetamine• Cocaine• Diet Pills• Caffeine • Nicotine

Drugs that Increase Eating

• Marijuana

Drugs that Increase Purging

• Alcohol• Caffeine• Ipecac• Laxatives• Diuretics

Treatment Philosophy

• While substance abuse and eating disorders have much in common, their treatment is based on very different philosophical approaches.

Treatment Philosophy

Alcohol/Drugs

Recovery• Restrict or abstain from

substance.

Control

• Abstinence – external imposed structures of control.

Eating Disorders

Recovery• Food as ally to sustain

life.

Control

• Inner Strengths with little external controls.

Alcohol/DrugsRecovery• Restrict or abstain from substance.Control

• Abstinence – external imposed structures of control.

Eating DisordersRecovery• Food as ally to sustain life.

Control

• Inner Strengths with little external controls.

Treatment of one disorder often leads to exacerbation of the other.

A majority of young woman diet at some point in time yet only a small fraction develop eating disorders.

Why?

Misplaced Blame

• Eating disorders have traditionally been viewed as psychiatric illnesses that are strongly influenced by social pressures towards thinness.

• Family Twin and molecular genetic studies support substantial genetic influences on eating disorders

Twin Studies

Prevalence, Heritability and Prospective Risk Factors

for Anorexia Nervosa

31,206 twins born between 1935-1958

Arch Gen Psychiatry. 2006;63:305-312

The Genetics of Eating Disorders

• Activation of the heritability of eating pathology may be mediated by hormones in puberty.

• Cultural attitudes toward thinness have relevance to the psycho-pathology of eating disorder, but they are unlikely to be sufficient to account for the pathogenesis of these disorders

Psychotropic Medication in the Treatment of Eating Disorders

Comorbidity of Eating Disorders

• The lifetime rates of psychiatric comorbidity among patients with Anorexia are approximately 80%

• The lifetime rates of psychiatric comorbidity among patients with Bulimia are approximately 83%

Bulimia Nervosa: A Chronic Persistent Illness

Approximately 50% of bulimic patients including those who have been treated continue to show eating disorder features on long term follow up.

Treatment Recommendations

• Antidepressants:

SSRI’s: Higher than “usual” antidepressant dosage may be required.

- Prozac 60mg/day considerably more effective than 20mg/day for reducing binge eating behavior and vomiting frequency.

- Celexa 40-60mg, Zoloft 100 – 200 mg.- The only medicine approved by the

FDA for BN is Fluoxetine.

Binge Eating Disorder – Pharmacologic Treatment

Celexa 40-60 mg x 6 weeks

Prozac 40-80 mg x 6 weeks

Luvox 100-300 mg x 9 weeks

Zoloft 100-200 mg x 6 weeks

All medication resulted in significant reduction in binge eating and body weight.

Psychopharmacology

• Antidepressants alone rarely lead to complete remission of Bulimic symptoms.

• Controlled studies have failed to demonstrate any advantage to adding an SSRI to nutritional and psychosocial interventions in the treatment of malnourished patients with AN

A retrospective study of SSRI treatment in adolescent Anorexia nervosa: insufficient evidence for efficacy

In conclusion, our results challenge the efficacy of SSRI medication in the treatment of eating disorder psychopathology as well as depressive and obsessive-compulsive comorbidity in adolescent AN. Clinicians should be chary in prescribing SSRI in adolescent AN unless randomized controlled trials have proofed the benefit of these drugs.

Journal of Psychiatric Research 39 (2005) 303-310

Fluoxetine After Weight Restoration in Anorexia Nervosa

A Randomized Controlled Trial

This study failed to demonstrate any benefit from fluoxetine in the treatment of patients with Anorexia Nervosa following weight restoration. Future efforts should focus on developing new models to understand the persistence of this illness and on exploring new psychological and pharmacological treatment approaches.

JAMA. 2006; 295:2605-2612

Anorexia

• Is Anorexia Nervosa a Psychotic Disorder?- Patients believe they are overweight when

they are dramatically under weight

- Misperceptions about body size and shape

- “ED Voice” telling patients not to eat

• Atypical Antipsychotics have clinically been shown to be helpful with anxiety, food and distorted body image.

A New Model

Referenced EEG

The Referenced EEG

• A patient’s pretreatment QEEG data is obtained and statistically compared with similar QEEG data from patients with known medication responsivity.

• The result is a prediction of the patient’s likely responsivity to particular medications.

• This, in turn, informs the treatment strategy for the patient.

The rEEG Conjecture

• Resting EEG is stable• (abundant literature references support this)

• Resting EEG Changes with Medications• (Abundant literature references support this)

• Use Medications to normalize the EEG• (CNSR proprietary rEEG technology)

• Normalized EEG leads to normalized behavior• (CNSR clinical results)

Case TwoAnorexia Nervosa, Bipolar Disorder, Posttraumatic Stress Disorder, Alcohol Abuse

I: History:– 33 year old female with a 20 year history of an eating disorder and compulsive excercise– Onset occurred after a sexual trauma in teen years– Flashbacks, hypervigilance, nightmares, mood lability – Bingeing and purging from 9am to 2pm daily and then from 2pm until 6pm she will consume

alcohol. Cocaine use, drinks 1 pint of vodka per day. – Hospitalizations: 5 inpatient eating disorder admissions

II: Past Medication Trials:– Ativan, , Effexor XR, Klonopin, Lexapro, Neurontin, Prozac, Topomax, Trileptal, Seroquel,

Lithium, Zoloft, Risperdal, , Xanax, ZyprexaIII: Reference EEG Medication Prediction:

– Anticonvulsant, Antidepressant and Stimulant combination– Prescribed

• Dexedrine, Neurontin, ProzacIV: Response:

– Eating disorder behavior free for first time in 20 years– Patient engaging voluntarily in outpatient treatment– No mood swings, cravings for alcohol– Able to hold steady job– “It’s scary how well my brain works. I still get sad and I still get happy, but I don’t do stupid

crazy things when I’m happy, or stuff my face with food when I’m sad, it’s manageable. Life is manageable.”

• Case S.S.

14 y/o male with AN - Neurontin, Adderall

22 y/o with AN/SA - Zoloft, Wellbutrin

24 y/o with BN/DA/ADHD - Trileptal, Wellbutrin, Concerta

24 y/o with AN/MDD - Lamictal, Parnate

16 y/o AN/MDD - Lamictal, Adderall

23 y/o BN - Neurontin, Dexadrine

16 y/o AN - Lamictal, Dexadrine

22 y/o AN - Trileptal, Cymbalta

22 y/o ED NOS - Depakote, Wellbutrin, Abilify

Treatment Options

There are no research studies to support an optimal treatment program for patients with substance abuse and co-morbid eating disorders.

• A multidisciplinary approach has to recognize that eating disorders and co-morbid substance abuse are complex and require:– Integrated, concurrent medical, nutritional and psychiatric

treatment.– A combination of different types of therapy, including group

therapy, family therapy, individual counseling, dialectal behavioral therapy (DBT) and other methods of treatment.

– Treatment of co-morbidities. Co-morbidities exist more often than not. They should be assumed to exist until absence can be demonstrated.

– Changing treatment as the patient progresses.• Continuum of Care

• Aggressive treatment is crucial as these disorders affect children and young adolescents when they are most vulnerable, quickly destroying their foundation for psychological development.

Thank You

Thank You